Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis— PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology
Year: 2017
Type: review
Abstract: This consensus document summarizes the current knowledge on the potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Precision medicine is an emerging approach for disease treatment based on disease endotypes, which are phenotypic subclasses associated with specific mechanisms underlying the disease. Although significant progress has been made in defining endotypes for asthma, definitions of endotypes for food and drug allergy or for anaphylaxis lag behind. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.
Source: Allergy
DOI: 10.1111/all.13132
Institutions: University of Wisconsin–Madison, Brigham and Women's Hospital, Harvard University, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, The University of Texas Southwestern Medical Center, University of Bern, Odense University Hospital, University of North Carolina at Chapel Hill, Copenhagen University Hospital, Gentofte Hospital, Icahn School of Medicine at Mount Sinai, Charité – Universitätsmedizin Berlin, Stanford Medicine, Stanford University
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4406597345
